VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ALURAllurion Technologies Inc.
$0.58$4M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ALUR logoAllurion Technologies Inc.(ALUR)Earnings, Financials & Key Ratios

ALUR•NYSE
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryPatient monitoring and wearable diagnostics
AboutAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.Show more
  • Revenue$15M-52.6%
  • EBITDA-$29M+40.7%
  • Net Income-$29M-10.0%
  • EPS (Diluted)-3.81+67.3%
  • Gross Margin62.84%-6.2%
  • EBITDA Margin-191.56%-25.0%
  • Operating Margin-198.01%-26.7%
  • Net Margin-188.81%-131.9%

ALUR Key Insights

Allurion Technologies Inc. (ALUR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Profits declining 461.1% over 5 years
  • ✗Weak Piotroski F-Score: 0/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 7 (bottom 7%)
  • ✗Shares diluted 100.0% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ALUR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ALUR Price & Volume

Allurion Technologies Inc. (ALUR) stock price & volume — 10-year historical chart

Loading chart...

ALUR Growth Metrics

Allurion Technologies Inc. (ALUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-38.1%
TTM-55.49%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM15.35%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM75.4%

Return on Capital

10 Years-445.02%
5 Years-549.75%
3 Years-876.95%
Last Year-

ALUR Recent Earnings

Allurion Technologies Inc. (ALUR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (40%)●Beat Revenue 4/12 qtrs (40%)
Q2 2026Latest
May 20, 2026
Metric
Actual
Est
EPS
$0.46-35.3%
$0.34
Rev
$3M-4.9%
$3M
Q2 2026
Apr 1, 2026
Metric
Actual
Est
EPS
$0.61+0.0%
$0.61
Rev
$3M+0.0%
$3M
Q4 2025
Nov 12, 2025
Metric
Actual
Est
EPS
$1.18-87.3%
$0.63
Rev
$3M-9.9%
$3M
Q3 2025
Aug 13, 2025
Metric
Actual
Est
EPS
$1.28-96.9%
$0.65
Rev
$3M-34.7%
$5M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 20, 2026
$0.46vs $0.34-35.3%
$3Mvs $3M-4.9%
Q2 2026Apr 1, 2026
$0.61vs $0.61+0.0%
$3Mvs $3M+0.0%
Q4 2025Nov 12, 2025
$1.18vs $0.63-87.3%
$3Mvs $3M-9.9%
Q3 2025Aug 13, 2025
$1.28vs $0.65-96.9%
$3Mvs $5M-34.7%
Based on last 12 quarters of dataView full earnings history →

ALUR Peer Comparison

Allurion Technologies Inc. (ALUR) competitors in Patient monitoring and wearable diagnostics — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GUTS logoGUTSFractyl Health, Inc. Common StockDirect Competitor61.96M0.86-0.46-100%-45.74%6.52
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
INVA logoINVAInnoviva, Inc.Product Competitor1.66B22.496.8218.52%118.91%47.59%0.23
ELMD logoELMDElectromed, Inc.Product Competitor320.27M38.6844.9816.97%14.08%22.14%0.00
NVO logoNVONovo Nordisk A/SSupply Chain191.93B43.1912.186.43%37.2%66.36%0.67
LLY logoLLYEli Lilly and CompanySupply Chain1.04T1098.1347.8544.7%34.98%101.17%1.60
AMGN logoAMGNAmgen Inc.Supply Chain182.2B337.6023.729.92%20.95%89.41%6.31
HIMS logoHIMSHims & Hers Health, Inc.Supply Chain7.79B35.4769.5559%-0.56%-2.48%2.34

Compare ALUR vs Peers

Allurion Technologies Inc. (ALUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GUTS

Most directly comparable listed peer for ALUR.

Scale Benchmark

vs LLY

Larger-name benchmark to compare ALUR against a more recognizable public peer.

Peer Set

Compare Top 5

vs GUTS, NVCR, INVA, ELMD

ALUR Income Statement

Allurion Technologies Inc. (ALUR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
038.24M64.21M53.47M32.11M15.23M12.6M
Revenue Growth %
--67.91%-16.73%-39.94%-52.57%-55.49%
Cost of Goods Sold
09.05M13.48M11.97M10.61M5.66M5.96M
COGS % of Revenue
-23.67%21%22.39%33.03%37.16%-
Gross Profit
0▲ 0%
29.19M▲ 0%
50.73M▲ 73.8%
41.5M▼ 18.2%
21.5M▼ 48.2%
9.57M▼ 55.5%
6.64M▲ 0%
Gross Margin %
-76.33%79%77.61%66.97%62.84%52.7%
Gross Profit Growth %
--73.78%-18.19%-48.18%-55.49%-
Operating Expenses
5.17K41.69M82.74M120.58M71.7M39.73M33.24M
OpEx % of Revenue
-109.02%128.85%225.51%223.3%260.85%-
Selling, General & Admin
4.56K35.96M65.77M92.88M54.33M32.16M27.39M
SG&A % of Revenue
-94.04%102.43%173.72%169.21%211.14%-
Research & Development
05.73M16.97M27.69M17.37M7.57M5.86M
R&D % of Revenue
-14.98%26.42%51.8%54.09%49.71%-
Other Operating Expenses
610000000
Operating Income
-5.17K▲ 0%
-12.5M▼ 241745.6%
-32.01M▼ 156.1%
-79.08M▼ 147.0%
-50.2M▲ 36.5%
-30.16M▲ 39.9%
-26.61M▲ 0%
Operating Margin %
--32.69%-49.85%-147.9%-156.33%-198.01%-211.21%
Operating Income Growth %
--241745.62%-156.06%-147.04%36.52%39.92%-
EBITDA
201.13K-11.79M-31.11M-78.33M-49.2M-29.17M-25.66M
EBITDA Margin %
--30.84%-48.46%-146.51%-153.23%-191.56%-203.66%
EBITDA Growth %
--5963.93%-163.82%-151.75%37.19%40.7%43.31%
D&A (Non-Cash Add-back)
206.3K707K895K746K997K983K951K
EBIT
-5.17K-8.72M-33.17M-69.78M-23.17M-28.68M-39.89M
Net Interest Income
0-3.67M-4.43M-10.57M-2.26M0-1.82M
Interest Income
0000000
Interest Expense
03.67M4.43M10.57M2.26M01.82M
Other Income/Expense
0115K-5.59M-1.26M24.77M1.48M-6.74M
Pretax Income
-5.17K▲ 0%
-12.39M▼ 239520.8%
-37.6M▼ 203.6%
-80.34M▼ 113.7%
-25.43M▲ 68.3%
-28.68M▼ 12.8%
-33.35M▲ 0%
Pretax Margin %
--32.39%-58.56%-150.27%-79.2%-188.32%-264.73%
Income Tax
00143K264K718K74K1K
Effective Tax Rate %
0%0%-0.38%-0.33%-2.82%-0.26%-0%
Net Income
-5.17K▲ 0%
-12.39M▼ 239520.8%
-37.74M▼ 204.7%
-80.61M▼ 113.6%
-26.15M▲ 67.6%
-28.75M▼ 10.0%
-33.35M▲ 0%
Net Margin %
--32.39%-58.78%-150.76%-81.43%-188.81%-264.74%
Net Income Growth %
--239520.82%-204.73%-113.56%67.56%-9.97%15.35%
Net Income (Continuing)
-5.17K-12.39M-37.74M-80.61M-26.15M-28.75M-33.35M
Discontinued Operations
0000000
Minority Interest
0000000
EPS (Diluted)
0.00▲ 0%
-0.25▲ 0%
-37.75▼ 15000.0%
-57.83▼ 53.2%
-11.64▲ 79.9%
-3.81▲ 67.3%
-2.50▲ 0%
EPS Growth %
---15000%-53.19%79.87%67.27%75.4%
EPS (Basic)
0.00-0.25-37.75-57.83-11.64-3.81-
Diluted Shares Outstanding
107.81M54.45M1.08M1.42M2.25M7.54M13.35M
Basic Shares Outstanding
107.81M54.42M999.74K1.39M2.25M75.45M133.51M
Dividend Payout Ratio
-------

ALUR Balance Sheet

Allurion Technologies Inc. (ALUR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
47.09K37.33M43.38M64.82M27.16M12.79M11.3M
Cash & Short-Term Investments
47.09K25.84M7.68M38.04M15.38M5.41M5.06M
Cash Only
47.09K25.84M7.68M38.04M15.38M5.41M5.06M
Short-Term Investments
0000000
Accounts Receivable
06.83M29.35M18.19M7.13M3.95M3.48M
Days Sales Outstanding
-65.21166.81124.281.0994.69125.01
Inventory
02.71M3.87M6.17M3.4M2.67M2.06M
Days Inventory Outstanding
-109.48104.61188.17117172.21186.36
Other Current Assets
002.49M2.41M1.24M759K712K
Total Non-Current Assets
282.88K2.02M7.99M6.9M5.66M2.98M2.69M
Property, Plant & Equipment
01.71M5.28M6.39M4.55M2.32M2.06M
Fixed Asset Turnover
-22.31x12.16x8.37x7.06x6.57x4.73x
Goodwill
0000000
Intangible Assets
0000000
Long-Term Investments
0862.55M0384K001M
Other Non-Current Assets
282.88K-862.24M2.71M121K1.11M663K302K
Total Assets
329.96K▲ 0%
39.35M▲ 11825.8%
51.37M▲ 30.5%
71.71M▲ 39.6%
32.81M▼ 54.2%
15.77M▼ 51.9%
13.99M▲ 0%
Asset Turnover
-0.97x1.25x0.75x0.98x0.97x0.66x
Asset Growth %
-11825.81%30.54%39.6%-54.24%-51.93%-219.21%
Total Current Liabilities
310.13K31.61M75.87M65.42M18.86M38.45M37.26M
Accounts Payable
01.62M5.81M10.38M6.57M3.57M3.06M
Days Payables Outstanding
-65.24157.23316.49226.15230.13203.28
Short-Term Debt
170K24.14M53.36M38.64M028.47M28.55M
Deferred Revenue (Current)
0202K00000
Other Current Liabilities
140.13K2.23M3.45M13.81M1.05M6.41M5.64M
Current Ratio
0.15x1.18x0.57x0.99x1.44x0.33x0.30x
Quick Ratio
0.15x1.09x0.52x0.90x1.26x0.26x0.25x
Cash Conversion Cycle
-109.44114.2-4.11-28.0636.77108.08
Total Non-Current Liabilities
042.02M7.82M76.77M91.93M54.52M54.65M
Long-Term Debt
02M3.1M36.2M35.71M571K455K
Capital Lease Obligations
002.16M2.31M1.34M02.87M
Deferred Tax Liabilities
0000000
Other Non-Current Liabilities
040.02M2.55M74.47M54.87M53.95M54.19M
Total Liabilities
310.13K73.64M83.68M142.2M110.79M92.96M91.91M
Total Debt
170K26.14M59.53M41.86M37.92M29.04M29.45M
Net Debt
122.91K300K51.85M3.82M22.54M23.63M24.39M
Debt / Equity
8.57x------0.38x
Debt / EBITDA
0.85x------1.15x
Net Debt / EBITDA
0.61x------0.95x
Interest Coverage
--2.38x-7.50x-6.60x-10.23x--21.92x
Total Equity
19.83K▲ 0%
-34.28M▼ 172985.9%
-32.31M▲ 5.7%
-70.49M▼ 118.1%
-77.98M▼ 10.6%
-77.19M▲ 1.0%
-77.91M▲ 0%
Equity Growth %
--172985.89%5.75%-118.13%-10.63%1.01%-31.22%
Book Value per Share
0.00-0.63-30.01-49.52-34.70-10.23-5.84
Total Shareholders' Equity
19.83K-34.28M-32.31M-70.49M-77.98M-77.19M-77.91M
Common Stock
2.16K51K3K5K3K6K6K
Retained Earnings
-5.17K-94.45M-132.19M-212.8M-222.21M-250.96M-257.06M
Treasury Stock
0000000
Accumulated OCI
000-700K-8.37M5.14M6.13M
Minority Interest
0000000

ALUR Cash Flow Statement

Allurion Technologies Inc. (ALUR) cash flow — operating, investing & free cash flow history

MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-35-14.33M-46.98M-63.98M-42.3M-28.95M-22.7M
Operating CF Margin %
--37.47%-73.17%-119.67%-131.73%-190.06%-
Operating CF Growth %
--40939900%-227.87%-36.19%33.89%31.57%183.54%
Net Income
-5.17K-12.39M-37.74M-80.61M-26.15M-28.75M-33.35M
Depreciation & Amortization
0707K2M746K997K983K951K
Stock-Based Compensation
0313K437K8.36M3.06M3.15M3.78M
Deferred Taxes
001.27M0000
Other Non-Cash Items
0-1.47M840K7.33M-21.8M3.5M18.9M
Working Capital Changes
5.13K-1.5M-13.79M194K1.6M-7.82M-4.1M
Change in Receivables
0-927K-22.82M-1.32M8.98M844K2.09M
Change in Inventory
0-1.28M-1.15M-3.71M543K-486K-332K
Change in Payables
0-488K3.32M4.66M-3.92M-3.14M-1.08M
Cash from Investing
0-912K-1.55M-1.61M-611K00
Capital Expenditures
0-912K-1.55M-1.61M-611K00
CapEx % of Revenue
-2.38%2.41%3%1.9%-0%
Acquisitions
0000000
Investments
-------
Other Investing
0000000
Cash from Financing
47.13K28.95M30.54M95.99M20.21M18.97M7.34M
Debt Issued (Net)
170K19.07M30.95M71K280K795K795K
Equity Issued (Net)
25K9.87M132K213K21.26M18.97M20.91M
Dividends Paid
0000000
Share Repurchases
0000000
Other Financing
-147.88K1K-548K95.7M-1.33M-795K-14.43M
Net Change in Cash
47.09K▲ 0%
13.7M▲ 29001.7%
-17.99M▼ 231.3%
30.4M▲ 268.9%
-22.7M▼ 174.7%
-9.98M▲ 56.1%
-15.35M▲ 0%
Free Cash Flow
-40▲ 0%
-15.24M▼ 38102400.0%
-48.53M▼ 218.4%
-65.59M▼ 35.1%
-42.91M▲ 34.6%
-28.95M▲ 32.5%
-22.7M▲ 0%
FCF Margin %
--39.85%-75.58%-122.67%-133.64%-190.06%-180.19%
FCF Growth %
--38102400%-218.42%-35.15%34.57%32.54%47.99%
FCF per Share
0.00-0.28-45.07-46.08-19.10-3.84-1.70
FCF Conversion (FCF/Net Income)
0.01x1.16x1.24x0.79x1.62x1.01x0.68x
Interest Paid
01.32M00000
Taxes Paid
0000000

ALUR Key Ratios

Allurion Technologies Inc. (ALUR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20212022202320242025TTM
Return on Equity (ROE)
-----44.17%
Return on Invested Capital (ROIC)
--122.91%---38.2%
Gross Margin
76.33%79%77.61%66.97%62.84%52.7%
Net Margin
-32.39%-58.78%-150.76%-81.43%-188.81%-264.74%
Debt / Equity
------0.38x
Interest Coverage
-2.38x-7.50x-6.60x-10.23x--21.92x
FCF Conversion
1.16x1.24x0.79x1.62x1.01x0.68x
Revenue Growth
-67.91%-16.73%-39.94%-52.57%-55.49%
Related:ALUR Dividend History·ALUR Revenue History·ALUR Price History·ALUR P/E History·ALUR Financial Ratios·ALUR Institutional Holders

ALUR SEC Filings & Documents

Allurion Technologies Inc. (ALUR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 27, 2026·SEC

Material company update

Mar 12, 2026·SEC

Material company update

Mar 2, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 30, 2026·SEC

FY 2025

Mar 27, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 15, 2026·SEC

FY 2025

Nov 17, 2025·SEC

FY 2025

Aug 19, 2025·SEC

ALUR Frequently Asked Questions

Allurion Technologies Inc. (ALUR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Allurion Technologies Inc. (ALUR) reported $12.6M in revenue for fiscal year 2025.

Allurion Technologies Inc. (ALUR) saw revenue decline by 52.6% over the past year.

Allurion Technologies Inc. (ALUR) reported a net loss of $33.3M for fiscal year 2025.

Dividend & Returns

Allurion Technologies Inc. (ALUR) had negative free cash flow of $22.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ALUR back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →

How much would $100/month in ALUR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →